Show simple item record

dc.contributor.authorDe-Bono, J
dc.date.accessioned2018-06-27T09:53:49Z
dc.date.issued2008
dc.identifierhttp://publications.icr.ac.uk/6858/
dc.identifier.citationMEDICINE, 2008, 36 (1), pp. 33 - 37
dc.identifier.issn0025-7974
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1946
dc.description.abstractSignificant progress has been made over recent years in understanding the molecular and cellular processes involved in cancer biology. The identification of several molecular targets which are involved in cancer development and progression has led to the development of novel, rationally designed, molecularly targeted agents which are currently being used or investigated in clinical practice. The different toxicity profiles, responses on imaging, and mechanisms of action of these targeted agents have implications for the way that clinical trials with these agents are conducted. This article reviews current molecularly targeted anticancer therapeutics, their future prospects, and the challenges they provide.
dc.format.extent33 - 37
dc.titleTargeted agents in cancer therapy
dc.typeJournal Article
rioxxterms.licenseref.startdate2008en_US
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfMEDICINE
pubs.issue1
pubs.notesnone Significant progress has been made over recent years in understanding the molecular and cellular processes involved in cancer biology. The identification of several molecular targets which are involved in cancer development and progression has led to the development of novel, rationally designed, molecularly targeted agents which are currently being used or investigated in clinical practice. The different toxicity profiles, responses on imaging, and mechanisms of action of these targeted agents have implications for the way that clinical trials with these agents are conducted. This article reviews current molecularly targeted anticancer therapeutics, their future prospects, and the challenges they provide.
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.volume36en_US
pubs.embargo.termsNot known
icr.researchteamProstate Cancer Targeted Therapy Groupen_US
dc.contributor.icrauthorDe Bono, Johannen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record